Innovative Eyewear, Inc. Common Stock (LUCY) is a publicly traded Healthcare sector company. As of July 6, 2026, LUCY trades at $1.54 with a market cap of $4.87M and a P/E ratio of -0.40. LUCY moved +95.39% today. Year to date, LUCY is -29.63%; over the trailing twelve months it is -64.81%. Its 52-week range spans $0.66 to $7.60. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces LUCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Innovative Eyewear Q2 Sales Surge 71% with Canadian 345-Store Deal, US Test: Innovative Eyewear’s preliminary Q2 net sales climbed 71% year-over-year to $0.99 million, driving first-half revenues of $1.77 million in its twelfth straight quarter of growth. The company secured a purchase order from a Canadian optical group covering 345 stores and a 50-store test with a major U.S. retailer.
| Metric | Value |
|---|---|
| Price | $1.54 |
| Market Cap | $4.87M |
| P/E Ratio | -0.40 |
| EPS | $-1.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.60 |
| 52-Week Low | $0.66 |
| Volume | 157.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.66M |
| Net Income | $-7.59M |
| Gross Margin | 21.32% |
1 analysts cover LUCY: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.